|
The KCE Trials team wishes you the best for 2021 ! Many thanks to research teams from Belgium and the Netherlands who jointly submitted projects to the BeNeFIT-2 call. KCE Trials and ZonMw have started the selection process. Three contracts have been signed last month for 2019 investigator-led Call studies, congrats to the successful applicants ! KCE Trials team |
Funding Opportunities
|
|
|
|
CALL OPEN The Covid-19 fast-track rolling call for clinical studies is still open for applications. The scope has been broadened to include vaccine studies, and priority in selection process will now be given to organisation of/participation to international initiatives. |
CALL CLOSED The BeNeFIT-2 call (a collaboration with ZonMw in the Netherlands) is now closed. 41 applications have been received, and review and selection process has started. Applicants can expect information on the status of their application around May 2021.
|
|
|
|
Progress in funded studies
We are happy to announce the following important milestones have been reached in the trials below:
|
BENEFICIAL study FPI |
The first patient has been recruited in the BENEFICIAL study, investigating the impact of bedside model-informed precision dosing of vancomycin in critically ill children. The Chief Investigator is Dr Dieter De Cock (UZ Gent). The study will recruit 390 patients from 8 hospitals, and is expected to last 28 months. Read more>> |
|
SurLym study OPEN |
The contract has been signed for the SurLym trial, comparing reconstructive surgery versus no surgery, additional to decongestive lymphatic therapy (usual care), for the treatment of lymphoedema. Prof Nele Devoogdt (UZ Leuven) is the Chief Investigator. The study will recruit 180 patients from 3 hospitals, and is expected to last 4 years (with follow-up period of 1.5 year). Read more>> |
|
HYFOIL study OPEN |
The contract has been signed for the HYFOIL study, investigating the impact on fertility after additional tubal flushing with oil-based contrast versus no additional flushing in infertile women. The Chief Investigator is Dr Diane De Neubourg (UZA). The study will recruit 736 patients from 12 hospitals, and is expected to last 4 years. The study has been submitted for regulatory and ethics approval under the pilot CTR project. Read more>> |
|
C-EASIE study OPEN |
The contract has been signed for the C-EASIE study, investigating the early administration of Vitamin C in patients with sepsis or septic shock in emergency departments. Dr Didier Desruelles (UZ Leuven) is the Chief Investigator. The study will recruit 300 patients from 8 hospitals, and is expected to last 27 months. The study has been submitted for regulatory and ethics approval under the pilot CTR project. Read more>> |
The KCE Trials complete portfolio comprises 32 studies. more info>>
Impact
The last scientific publications are presented here.
|
Protocol Dawn Plasma study |
November 2020 |
|
|
Results ELMO study |
November 2020 |
|
|
Results Pressure Ulcer Prevention study |
November 2020 |
Check our dynamic dashboard for real-time recruitment data for all KCE Trials funded studies
